Regions Financial Corp’s Ligand Pharmaceuticals LGND Stock Holding History

Regions Financial Corp’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-242	Closed	-$19K	–	1323
2019 Q1	$19K	Sell	242 -3,703	-94%	-$281K	﹤0.01%	1379
2018 Q4	$334K	Buy	3,945 +777	+25%	+$82.8K	﹤0.01%	607
2018 Q3	$543K	Sell	3,168 -1,324	-29%	-$200K	0.01%	550
2018 Q2	$581K	Sell	4,492 -569	-11%	-$63.5K	0.01%	519
2018 Q1	$522K	Sell	5,061 -322	-6%	-$31.8K	0.01%	547
2017 Q4	$459K	Sell	5,383 -614	-10%	-$53.2K	0.01%	615
2017 Q3	$509K	Buy	+5,997	New	+$475K	0.01%	620

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Regions Financial Corp's LGND Position: Q2 2019 in Review

Regions Financial Corp sold out of Ligand Pharmaceuticals (LGND) in Q2 2019, closing a stake of 242 shares — an estimated $19K sold.

Regions Financial Corp first reported a position in LGND in Q3 2017 and held it in 7 quarters. The position peaked at $581K in Q2 2018. 305 funds tracked by Wall St. Rank hold LGND as of Q2 2019.

Regions Financial Corp reported no remaining Ligand Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Regions Financial Corp sold 242 Ligand Pharmaceuticals shares in Q2 2019, an estimated $19K.
Regions Financial Corp first reported a position in Ligand Pharmaceuticals in Q3 2017 and held it in 7 quarters.
Regions Financial Corp's Ligand Pharmaceuticals position peaked at $581K in Q2 2018.
305 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.